Thomas Smith
Stock Analyst at Leerink Partners
(1.27)
# 1714
Out of 5,331 analysts
103
Total ratings
30.16%
Success rate
15.86%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
EQ Equillium | Downgrades: Market Perform | 3 1 | 0.42 | 138.1% | 4 | Mar 28, 2025 | |
QTTB Q32 Bio | Downgrades: Market Perform | 68 9 | 1.64 | 448.78% | 2 | Dec 11, 2024 | |
ACRS Aclaris Therapeutics | Upgrades: Outperform | 2 7 | 1.45 | 382.76% | 7 | Nov 19, 2024 | |
ALMS Alumis | Initiates Coverage On: Outperform | 29 | 4.55 | 537.36% | 1 | Jul 23, 2024 | |
RNAC Cartesian Therapeuti... | Initiates Coverage On: Outperform | 39 | 12.8 | 204.69% | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 42 65 | n/a | n/a | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 26 | 3.81 | 582.41% | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 10 | 0.96 | 941.67% | 2 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 33 | n/a | n/a | 2 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 7.19 | 178.16% | 1 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 17 | n/a | n/a | 3 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 56 | n/a | n/a | 1 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 430 435 | 649.62 | -33.04% | 3 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 17 18 | n/a | n/a | 7 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 36 | 49.5 | -27.27% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 7 | 0.83 | 743.37% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 21 | 15.82 | 32.74% | 6 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 45 | 13.64 | 229.91% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | 6.99 | -14.16% | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 19 | n/a | n/a | 2 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 30 20 | n/a | n/a | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | 5 | 20% | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 9 5 | 1.15 | 334.78% | 3 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 77 | n/a | n/a | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 42.34 | -59.85% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 60 | n/a | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 64 | 20.73 | 208.73% | 2 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 66 70 | 17.66 | 296.38% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 225 150 | n/a | n/a | 5 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 29 | 8.72 | 232.57% | 5 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 33 26 | 3.31 | 685.5% | 3 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 13 12 | 0.33 | 3536.36% | 4 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 29.41 | -59.2% | 2 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 10 | 4.3 | 132.56% | 4 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 675 400 | 3.05 | 13014.75% | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 80 | 14.64 | 446.45% | 2 | Dec 8, 2020 |